Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1963 1
1964 1
1965 1
1966 1
1967 2
1970 2
1971 1
1975 1
1976 1
1977 1
1978 3
1979 1
1981 2
1982 1
1983 2
1984 2
1985 2
1986 2
1987 3
1988 3
1989 6
1990 3
1992 2
1993 4
1994 4
1995 4
1996 3
1997 11
1998 3
1999 4
2000 6
2001 3
2002 5
2003 7
2004 10
2005 10
2006 11
2007 13
2008 12
2009 14
2010 9
2011 15
2012 15
2013 17
2014 27
2015 20
2016 21
2017 17
2018 28
2019 12
2020 19
2021 34
2022 34
2023 24
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

414 results

Results by year

Filters applied: . Clear all
Page 1
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA, Grupp SA. Maude SL, et al. Among authors: hiramatsu h. N Engl J Med. 2018 Feb 1;378(5):439-448. doi: 10.1056/NEJMoa1709866. N Engl J Med. 2018. PMID: 29385370 Free PMC article. Clinical Trial.
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Laetsch TW, Maude SL, Rives S, Hiramatsu H, Bittencourt H, Bader P, Baruchel A, Boyer M, De Moerloose B, Qayed M, Buechner J, Pulsipher MA, Myers GD, Stefanski HE, Martin PL, Nemecek E, Peters C, Yanik G, Khaw SL, Davis KL, Krueger J, Balduzzi A, Boissel N, Tiwari R, O'Donovan D, Grupp SA. Laetsch TW, et al. Among authors: hiramatsu h. J Clin Oncol. 2023 Mar 20;41(9):1664-1669. doi: 10.1200/JCO.22.00642. Epub 2022 Nov 18. J Clin Oncol. 2023. PMID: 36399695 Free PMC article. Clinical Trial.
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia.
Pulsipher MA, Han X, Maude SL, Laetsch TW, Qayed M, Rives S, Boyer MW, Hiramatsu H, Yanik GA, Driscoll T, Myers GD, Bader P, Baruchel A, Buechner J, Stefanski HE, Kalfoglou C, Nguyen K, Waldron ER, Thudium Mueller K, Maier HJ, Kari G, Grupp SA. Pulsipher MA, et al. Among authors: hiramatsu h. Blood Cancer Discov. 2022 Jan;3(1):66-81. doi: 10.1158/2643-3230.BCD-21-0095. Epub 2021 Dec 1. Blood Cancer Discov. 2022. PMID: 35019853 Free PMC article.
["Itai-itai" disease].
Hiramatsu H, Hisada K, Takashima T. Hiramatsu H, et al. Rinsho Hoshasen. 1970 Dec;15(12):877-86. Rinsho Hoshasen. 1970. PMID: 4923355 Review. Japanese. No abstract available.
Clinical landscape of TP73 structural variants in ATL patients.
Hiramatsu H, Yokomori R, Shengyi L, Tanaka N, Mori S, Kiyotani K, Gotoh O, Kusumoto S, Nakano N, Suehiro Y, Ito A, Choi I, Ohtsuka E, Hidaka M, Nosaka K, Yoshimitsu M, Imaizumi Y, Iida S, Utsunomiya A, Noda T, Nishikawa H, Ueda R, Sanda T, Ishida T. Hiramatsu H, et al. Leukemia. 2023 Dec;37(12):2502-2506. doi: 10.1038/s41375-023-02059-9. Epub 2023 Oct 20. Leukemia. 2023. PMID: 37864123 Free PMC article. No abstract available.
Safety and efficacy of post-haematopoietic cell transplantation maintenance therapy with blinatumomab for relapsed/refractory CD19-positive B-cell acute lymphoblastic leukaemia: protocol for a phase I-II, multicentre, non-blinded, non-controlled trial (JPLSG SCT-ALL-BLIN21).
Sakaguchi H, Umeda K, Kato I, Sakaguchi K, Hiramatsu H, Ishida H, Yabe H, Goto H, Kawahara Y, Yamashita YI, Sanada M, Deguchi T, Takahashi Y, Saito A, Noma H, Horibe K, Taga T, Adachi S; Transplantation and Cellular Therapy Committee of Japanese Childhood Cancer Group. Sakaguchi H, et al. Among authors: hiramatsu h. BMJ Open. 2023 Apr 17;13(4):e070051. doi: 10.1136/bmjopen-2022-070051. BMJ Open. 2023. PMID: 37068890 Free PMC article.
414 results